Nebraska Methodist Cancer Center — Omaha, Nebraska

Nebraska Methodist Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Clinical Trials Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Nebraska Methodist Cancer Center has participated in 17 clinical trials.

Therapeutic areas: Non Small Cell Lung Cancer, Extensive-Stage Small Cell Lung Cancer, Carcinoma.

Sponsors: SCRI Development Innovations, LLC, Eli Lilly and Company, Human Genome Sciences Inc..

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Methodist Cancer Center?

Nebraska Methodist Cancer Center has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Methodist Cancer Center conducted?

Nebraska Methodist Cancer Center has 17 clinical trials on record. Their work covers Non Small Cell Lung Cancer, Extensive-Stage Small Cell Lung Cancer, Carcinoma.

Is Nebraska Methodist Cancer Center accredited by Crixeo Clinical Trials?

Nebraska Methodist Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Methodist Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.